University hospital
Poitiers, Vienne, 86021, France
NCT Number: NCT00259350
The best antiseptic solution for cateheter care remains unknown.High concentration in aquous solution or low concentration in alcoholic solution of chlorhexidine actbetter than povidone iodine in aquous solutions. No study has compare alcoholic formulations of low concentration of chlorhexidine and povidone iodine for skin disinfection prior to insertion of central venous catheters.
To compare the incidence of central venous catheter colonization after skin disinfection with either an alcoholic solution of povidone iodine or a combination of 0.5% chlorhexidine, 0.025% Benzalkonium and 4% benzylic alcohol.
To compare the incidence of catheter related bacteremia in the to study groups. To compare the local and general tolerance of the two antiseptic formulations
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Poitiers, Vienne, 86021, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Looking for future studies?
Notify MePoitiers University Hospital
Other
Prevention of Central Venous Catheter Infections : Comparison of the Efficacy of Skin Disinfection With 5% Povidone Iodine in Alcoholic Solution Versus 0.25% Chlorhexidine, 0.025 Benzalkonium and 4% Benzylic Alcohol
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03573739
Critical Illness, Critical Illness Myopathy
Saint-Denis, La Réunion, France
View Trial DetailsNCT01802099
Acute Respiratory Failure, Cross Infection
Amiens, France
View Trial DetailsNCT06788405
Cross Infection, Disease Attributes
Istanbul, Avcılar, Turkey (Türkiye)
View Trial DetailsNCT06628076
Cross Infection, Disease Attributes
Sohag, Egypt
View Trial Details